Prostate Cancer - PSA

Prostate cancer is the most frequent malignant neoplasm in men and the second most common cancer to cause death among American men. Serum prostate specific antigen (PSA) testing is currently recommended for early detection of prostate cancer; digital rectal examination (DRE) should be used in men with an increased PSA but is not recommended for use as a stand-alone test (National Comprehensive Cancer Network [NCCN] Prostate Cancer Early Detection guideline, 2018). Other biomarkers are used to stratify risk.

Tabs Content
Content Review: 
June 2018

Last Update: October 2018